Key result
Concomitant respiratory infections in AMI-CS admissions were associated with lower in-hospital mortality despite higher resource use.
Why the study?
The prevalence and impact of respiratory infections in cardiogenic shock complicating acute myocardial infarction were not well defined.
Do concomitant respiratory infections impact in-hospital mortality and resource utilization in patients admitted with acute myocardial infarction complicated by cardiogenic shock?
Observational (n=557,974)
Yes
Do concomitant respiratory infections impact in-hospital mortality and resource utilization in patients admitted with acute myocardial infarction complicated by cardiogenic shock?
Concomitant respiratory infections in AMI-CS admissions are associated with higher resource utilization but paradoxically lower in-hospital mortality.
Answers are grounded in this paper and cite their sources.
Respiratory infections in AMI-CS warrant no practice change; leaves open confounding and needs prospective validation.
To evaluate the prevalence and impact of respiratory infections in cardiogenic shock complicating acute myocardial infarction (AMI-CS). Using the National Inpatient Sample (2000–2017), this study identified adult (≥18 years) admitted with AMI-CS complicated by respiratory infections. Outcomes of interest included in-hospital mortality of AMI-CS admissions with and without respiratory infections, hospitalization costs, hospital length of stay, and discharge disposition. Temporal trends of prevalence, in-hospital mortality and cardiac procedures were evaluated. Among 557,974 AMI-CS admissions, concomitant respiratory infections were identified in 84,684 (15.2%). Temporal trends revealed a relatively stable trend in prevalence of respiratory infections over the 18-year period. Admissions with respiratory infections were on average older, less likely to be female, with greater comorbidity, had significantly higher rates of NSTEMI presentation, and acute non-cardiac organ failure compared to those without respiratory infections (all p < 0.001). These admissions received lower rates of coronary angiography (66.8% vs 69.4%, p < 0.001) and percutaneous coronary interventions (44.8% vs 49.5%, p < 0.001), with higher rates of mechanical circulatory support, pulmonary artery catheterization, and invasive mechanical ventilation compared to AMI-CS admissions without respiratory infections (all p < 0.001). The in-hospital mortality was lower among AMI-CS admissions with respiratory infections (31.6% vs 38.4%, adjusted OR 0.58 [95% CI 0.57–0.59], p < 0.001). Admissions with respiratory infections had longer lengths of hospital stay (127, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20 vs 63, 4, 5, 6, 7, 8, 9, 10, 11 days, p < 0.001), higher hospitalization costs and less frequent discharges to home (27.1% vs 44.7%, p < 0.001). Respiratory infections in AMI-CS admissions were associated with higher resource utilization but lower in-hospital mortality.
No takes yet. Share an insight, caveat, or question.
Patlolla et al. (2021) conducted an observational in cardiogenic shock complicating acute myocardial infarction (AMI-CS) (n=557,974). Concomitant respiratory infections vs. No respiratory infections was evaluated on in-hospital mortality (OR 0.58, 95% CI 0.57-0.59, p=<0.001). Concomitant respiratory infections in AMI-CS admissions were associated with lower in-hospital mortality despite higher resource use.
Synapse has enriched 10 related papers. Consider them for comparative context: